Christine Desiree Marbury, | |
17246 Milton Dr, French Settlement, LA 70733-2419 | |
(225) 505-5847 | |
Not Available |
Full Name | Christine Desiree Marbury |
---|---|
Gender | Female |
Speciality | Licensed Practical Nurse |
Location | 17246 Milton Dr, French Settlement, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386313500 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
164W00000X | Licensed Practical Nurse | 20160761 (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Christine Desiree Marbury, 17246 Milton Dr, French Settlement, LA 70733-2419 Ph: (225) 505-5847 | Christine Desiree Marbury, 17246 Milton Dr, French Settlement, LA 70733-2419 Ph: (225) 505-5847 |
News Archive
As an official partner of the First World Congress on Healthy Ageing, Pfizer reaffirms the company's commitment to promote healthy and active ageing at all stages of life as a basis for enhanced productivity in the Asia Pacific. Pfizer will lead a luncheon symposium today focused on the relationship between health and economic sustainability and the resulting challenges and opportunities of shifting demographics across the region.
A new University of British Columbia study identifies an important molecular change that occurs in the brain when we learn and remember.
Survey data reveals a high degree of medical consensus that shaking a young child is capable of producing subdural hematoma (a life-threatening pooling of blood outside the brain), severe retinal hemorrhage, coma or death, according to a study published in The Journal of Pediatrics.
Immucor, Inc., a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that its fourth generation automated instrument, NEO™, has been cleared for marketing in the U.S. by the Food and Drug Administration ("FDA"). NEO is a fully automated blood bank instrument designed to meet the needs of high volume laboratories.
In their paper available on the medRxiv preprint server, researchers from Russia showed that patients with moderate and severe coronavirus disease (COVID-19) have a high incidence of deep vein thrombosis – indicating that they may necessitate an early administration of anticoagulation therapy as a part of their treatment regimen.
› Verified 7 days ago